321 related articles for article (PubMed ID: 19527020)
1. FOG: Fragment Optimized Growth algorithm for the de novo generation of molecules occupying druglike chemical space.
Kutchukian PS; Lou D; Shakhnovich EI
J Chem Inf Model; 2009 Jul; 49(7):1630-42. PubMed ID: 19527020
[TBL] [Abstract][Full Text] [Related]
2. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.
Blum LC; Reymond JL
J Am Chem Soc; 2009 Jul; 131(25):8732-3. PubMed ID: 19505099
[TBL] [Abstract][Full Text] [Related]
3. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?
Ajay A; Walters WP; Murcko MA
J Med Chem; 1998 Aug; 41(18):3314-24. PubMed ID: 9719583
[TBL] [Abstract][Full Text] [Related]
4. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.
Feher M; Schmidt JM
J Chem Inf Comput Sci; 2003; 43(1):218-27. PubMed ID: 12546556
[TBL] [Abstract][Full Text] [Related]
5. A scoring scheme for discriminating between drugs and nondrugs.
Sadowski J; Kubinyi H
J Med Chem; 1998 Aug; 41(18):3325-9. PubMed ID: 9719584
[TBL] [Abstract][Full Text] [Related]
6. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?
Newman DJ
J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402
[No Abstract] [Full Text] [Related]
7. Developing a drug-like natural product library.
Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
[TBL] [Abstract][Full Text] [Related]
8. Natural product-likeness score and its application for prioritization of compound libraries.
Ertl P; Roggo S; Schuffenhauer A
J Chem Inf Model; 2008 Jan; 48(1):68-74. PubMed ID: 18034468
[TBL] [Abstract][Full Text] [Related]
9. De novo drug design.
Hartenfeller M; Schneider G
Methods Mol Biol; 2011; 672():299-323. PubMed ID: 20838974
[TBL] [Abstract][Full Text] [Related]
10. Chemical fragment spaces for de novo design.
Mauser H; Stahl M
J Chem Inf Model; 2007; 47(2):318-24. PubMed ID: 17300171
[TBL] [Abstract][Full Text] [Related]
11. A scalable approach to combinatorial library design for drug discovery.
Sharma P; Salapaka S; Beck C
J Chem Inf Model; 2008 Jan; 48(1):27-41. PubMed ID: 18052333
[TBL] [Abstract][Full Text] [Related]
12. Model-free drug-likeness from fragments.
Ursu O; Oprea TI
J Chem Inf Model; 2010 Aug; 50(8):1387-94. PubMed ID: 20726597
[TBL] [Abstract][Full Text] [Related]
13. Diversity-oriented synthesis; a spectrum of approaches and results.
Spandl RJ; Bender A; Spring DR
Org Biomol Chem; 2008 Apr; 6(7):1149-58. PubMed ID: 18362950
[TBL] [Abstract][Full Text] [Related]
14. De novo drug design using multiobjective evolutionary graphs.
Nicolaou CA; Apostolakis J; Pattichis CS
J Chem Inf Model; 2009 Feb; 49(2):295-307. PubMed ID: 19434831
[TBL] [Abstract][Full Text] [Related]
15. Flux (1): a virtual synthesis scheme for fragment-based de novo design.
Fechner U; Schneider G
J Chem Inf Model; 2006; 46(2):699-707. PubMed ID: 16563000
[TBL] [Abstract][Full Text] [Related]
16. SYNOPSIS: SYNthesize and OPtimize System in Silico.
Vinkers HM; de Jonge MR; Daeyaert FF; Heeres J; Koymans LM; van Lenthe JH; Lewi PJ; Timmerman H; Van Aken K; Janssen PA
J Med Chem; 2003 Jun; 46(13):2765-73. PubMed ID: 12801239
[TBL] [Abstract][Full Text] [Related]
17. CLEVER: pipeline for designing in silico chemical libraries.
Song CM; Bernardo PH; Chai CL; Tong JC
J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
[TBL] [Abstract][Full Text] [Related]
18. Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.
Vieth M; Erickson J; Wang J; Webster Y; Mader M; Higgs R; Watson I
J Med Chem; 2009 Oct; 52(20):6456-66. PubMed ID: 19791746
[TBL] [Abstract][Full Text] [Related]
19. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
Guo ZR
Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
[TBL] [Abstract][Full Text] [Related]
20. A minimalist fragment approach for the design of natural-product-like synthetic scaffolds.
Genis D; Kirpichenok M; Kombarov R
Drug Discov Today; 2012 Nov; 17(21-22):1170-4. PubMed ID: 22659098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
